Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia
- PMID: 25600314
- PMCID: PMC4306267
- DOI: 10.12659/MSM.892919
Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia
Abstract
Background: The objective of this study was to perform a systematic review of correlations between the single-nucleotide polymorphism at nucleotide 309 (single-nucleotide polymorphism, SNP309) in the murine double-minute 2 (MDM2) gene promoter and susceptibility to leukemia.
Material/methods: We performed a computer search of relevant case-control studies published from January 1990 to Jan 2014 in databases such as Ovid, EBSCO, PubMed, CNKI, CBMDISC, VIP, and WanFang Data. The literature was screened based on inclusion and exclusion criteria. The data were retrieved, and the quality of the methodology used in the studies was evaluated. A meta-analysis was performed by calculating the combined odds ratios (OR) and 95% confidence intervals (CI) using RevMan 5.0 and Stata 10.0 software. Sensitivity was analyzed and publication bias was assessed.
Results: A total of ten case-control studies from nine research papers were selected in this study, which included 1889 cases and 5707 controls. Meta-analysis showed that people who carried the G allele had increased susceptibility to leukemia compared to people who carried the T allele [OR=1.24, 95% CI (1.06, 1.45), P=0.007]. In a recessive model, the GG homozygotic population had a higher risk of leukemia than the heterozygotic GT+TT population [OR=1.47, 95% CI (1.11, 1.96), P=0.008]. We did not find significant difference in a dominant model [GG+GT vs. TT: OR=1.22, 95% CI (0.98, 1.52), P=0.07]. Publication bias was not significant.
Conclusions: SNP309 polymorphism in the MDM2 gene is associated with susceptibility to leukemia. The G allele may be a risk factor for leukemia.
Figures




Similar articles
-
Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.Medicine (Baltimore). 2016 Mar;95(12):e2941. doi: 10.1097/MD.0000000000002941. Medicine (Baltimore). 2016. PMID: 27015167 Free PMC article.
-
MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.Leuk Lymphoma. 2012 Nov;53(11):2245-52. doi: 10.3109/10428194.2012.691485. Epub 2012 Jun 12. Leuk Lymphoma. 2012. PMID: 22563815
-
Correlations between the COMT gene rs4680 polymorphism and susceptibility to ovarian cancer.Genet Mol Res. 2015 Dec 14;14(4):16813-8. doi: 10.4238/2015.December.14.8. Genet Mol Res. 2015. PMID: 26681027
-
Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.Asian Pac J Cancer Prev. 2012;13(6):2841-6. doi: 10.7314/apjcp.2012.13.6.2841. Asian Pac J Cancer Prev. 2012. PMID: 22938470
-
MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Hum Cell. 2011 Jun;24(2):57-64. doi: 10.1007/s13577-011-0013-4. Epub 2011 Mar 4. Hum Cell. 2011. PMID: 21547352 Review.
Cited by
-
Upregulation of Leukocytic Syncytin-1 in Acute Myeloid Leukemia Patients.Med Sci Monit. 2016 Jul 9;22:2392-403. doi: 10.12659/msm.899303. Med Sci Monit. 2016. PMID: 27393911 Free PMC article.
-
The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis.Med Sci Monit. 2022 Mar 29;28:e935671. doi: 10.12659/MSM.935671. Med Sci Monit. 2022. PMID: 35347102 Free PMC article.
-
Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3037-3041. doi: 10.31557/APJCP.2019.20.10.3037. Asian Pac J Cancer Prev. 2019. PMID: 31653152 Free PMC article.
References
-
- Satoh Y, Matsumura I, Tanaka H, et al. C-terminal mutation of RUNXl attenuates the DNA-damage repair response in hematopoietic stem cells. Leukemia. 2012;26:303–11. - PubMed
-
- Mühlbacher V, Zenger M, Schnittger S, et al. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93% Genes Chromosomes Cancer. 2014;53:524–36. - PubMed
-
- Chen J, Zhu B, Chen J, Li Y. Genetic variations in MDM2 and P53 genes confer risk for adult acute lymphoblastic leukemia in a Chinese population. DNA Cell Biol. 2013;32:414–19. - PubMed
-
- Vogelstein B, Lane D, Levine AI. Surfingthe P53 network. Nature. 2000;408:307–10. - PubMed
-
- Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol. 2003;13:49–58. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous